To support the introduction of a change in Burkina Faso’s infant pneumococcal vaccine schedule to include a booster dose and to evaluate the impact of the country’s capacity to control pneumococcal disease among children and adults.

To reduce the incidence of the rodent-borne disease hantavirus among residents of the Navajo Nation by preventing exposure to the virus through empowering residents to repair and reinforce their homes against rodents, notably deer mice, the vector species for hantavirus.

To honor and recognize important work to promote safe injection practices and patient safety and produce educational materials that raise awareness and highlight the work of the One & Only Campaign.

To evaluate a polymer-based in-situ forming implant and its ability to provide long-lasting protection against HIV infection.

To conduct a birth cohort study in Nicaragua to better understand the epidemiology, immunity and transmission patterns of sapovirus using next-generation sequencing strategies.

To evaluate a polymer-based in-situ forming implant and its ability to provide long-lasting protection against HIV infection.

To capture the successes and challenges that arise with a national introduction of the HPV vaccine in low-and lower-middle income countries and to gain a better understanding of program transition to national scale-up, program preparation and communication, program delivery and financial implications for long-term sustainability.

To evaluate the norovirus component of the Vergene II gastrointestinal diagnostic assay platform.

To provide a case-control study comparing naturally occurring group B strep antibodies in young infants with invasive disease versus controls will establish antibody thresholds associated with protection and inform decisions about future maternal Group B Streptococcus vaccine licensure.

To evaluate the efficacy of vaginal film for microbicide delivery as a long-acting, low-cost human immunodeficiency virus (HIV) prevention method.